Saturday 17 October 2026 Export REGN’s income statement to Excel — free account

Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.3 billion, up 0.99% from fiscal 2024. In the quarter to June 2026, revenue grew 16.7%, EPS fell 4.68%, free cash flow fell 29.3% and total debt fell 26.6%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for three consecutive years.

790.74 5.60 −0.70%

Follow REGN

Alert me

Market cap: $82.0B
P/E: 18.9×
Fwd P/E: 16.5×
Dividend yield: 0.47%
F-score: 5/9
Altman Z: 7.49
Beneish M: −2.53
Dividend safety: 77/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	14.88	18.17	17.90	12.94	+8 more quarters Free account
P/S ratio Full definition →	4.13	5.39	5.63	4.09
P/FCF ratio Full definition →	17.93	21.20	21.44	15.01
P/Operating CF Full definition →	78.84	74.48	68.97	35.99
P/B ratio Full definition →	2.02	2.56	2.58	1.88
Price to Tangible BV Full definition →	2.11	2.67	2.69	1.97
EV/Sales Full definition →	3.84	5.03	5.32	3.79
EV/EBITDA Full definition →	13.63	18.01	18.52	12.82
EV/Operating CF Full definition →	12.73	14.98	15.33	10.65
EV/FCF Full definition →	16.67	19.81	20.27	13.92
Quick Ratio Full definition →	2.63	2.84	3.28	3.19
Current Ratio Full definition →	3.34	3.57	4.13	4.06
Net Debt/EBITDA Full definition →	(4.24)	(8.83)	(5.76)	(4.93)
Debt/Assets Full definition →	4.76%	4.86%	6.67%	6.74%
Debt/Equity Full definition →	0.06	0.06	0.09	0.09
Asset Turnover Full definition →	0.39	0.38	0.37	0.37
Operating CF/Net income Full definition →	0.63	1.48	1.39	1.11
Capex/Depreciation Full definition →	(2.35)	(2.27)	(2.00)	(1.79)
Interest Coverage Full definition →	117.59	49.84	72.12	53.20
Research and Development Expense of Revenue Full definition →	38.03%	42.81%	41.86%	39.29%
Selling, General and Administrative Expense of Revenue Full definition →	15.43%	17.96%	19.95%	17.52%
Intangible Assets out of Total Assets Full definition →	0.03	0.03	0.03	0.03
Share Based Compensation of Revenue Full definition →	5.66%	7.14%	6.42%	6.31%
Graham Net Nets Full definition →	0.13	0.11	0.11	0.15
Graham Number Full definition →	539.34	537.71	538.44	540.43
Earnings Yield Full definition →	6.72%	5.50%	5.59%	7.73%
Free Cash Flow Yield Full definition →	5.58%	4.72%	4.66%	6.66%
Revenue per Share Full definition →	41.74	34.67	37.13	36.24
Operating CF per Share Full definition →	7.91	10.37	11.19	15.62
Capex per Share Full definition →	(2.83)	(2.69)	(2.78)	(2.36)
Free Cash Flow per Share Full definition →	5.08	7.69	8.41	13.26
Cash per Share Full definition →	77.77	84.17	82.27	81.50
Shareholders Equity per Share Full definition →	308.48	302.15	298.82	298.82
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	308.48	302.15	298.82	298.82
Free Cash Flow Full definition →	521.80	799.40	880.00	1,374.00
Working Capital Full definition →	12,915.40	13,101.50	13,653.50	13,555.60
Capital Expenditures Full definition →	(291.20)	(279.50)	(290.70)	(244.70)
Net Current Asset Value Full definition →	8,426.80	8,764.00	8,720.10	8,769.10
EV/EBIT Full definition →	15.51	20.69	21.34	14.64
Capex to Sales Full definition →	0.07	0.08	0.07	0.07
Price to Operating Income Full definition →	16.68	22.14	22.57	15.79
Other line items
Average Receivables Full definition →	6,087.70	5,646.00	5,976.50	5,897.10
Average Payables Full definition →	941.60	866.30	864.25	700.55
Average Inventory Full definition →	3,144.95	3,148.00	3,144.05	3,136.20
Average Assets Full definition →	39,974.90	39,207.00	39,159.05	38,805.65
Average Common Equity Full definition →	30,825.15	30,405.60	30,305.25	30,141.85

Show all line items

Columns are period end dates

Stockrow Weekly